A Systematic Review of Opioid Conversion Ratios Used with Methadone for the Treatment of Pain

10.1016/0304-3940(95)11364-3

10.1016/S0304-3940(97)13391-2

Codd, 1995, Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: Structural determinants and role in antinociception, J Pharmacol Exp Ther, 274, 1263

10.1016/S0014-2999(99)00270-8

10.1016/0304-3959(94)00257-F

10.1002/(SICI)1097-0142(19980315)82:6<1167::AID-CNCR23>3.0.CO;2-3

Mercadante, 2003, Opioid plasma concentration during switching from morphine to methadone: Preliminary data, Support Care Cancer, 11, 326, 10.1007/s00520-003-0440-1

Mercadante, 1999, Rapid switching from morphine to methadone in cancer patients with poor response to morphine, J Clin Oncol, 17, 3307, 10.1200/JCO.1999.17.10.3307

Mercadante, 2001, Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: A prospective study, J Clin Oncol, 19, 2898, 10.1200/JCO.2001.19.11.2898

10.1016/0140-6736(93)92228-L

10.1177/104990910101800312

Ripamonti, 1998, Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: Comparison of two clinical experiences, Ann Oncol, 9, 79, 10.1023/A:1008263910494

Ripamonti, 1998, Switching from morphine to oral methadone in treating cancer pain: What is the equianalgesic dose ratio?, J Clin Oncol, 16, 3216, 10.1200/JCO.1998.16.10.3216

10.1046/j.1365-2354.1999.00133.x

10.1177/104990910001700314

10.1007/s005200000180

10.1089/10966210252785097

10.1080/J354v16n01_04

10.1046/j.1526-4637.2002.02047.x

Manfredi, 2003, Prescribing methadone, a unique analgesic, J Support Oncol, 1, 216

10.1177/104990910502200312

Toombs, 2005, Methadone treatment for pain states, Am Fam Physician, 71, 1353

Manfredonia, 2005, Prescribing methadone for pain management in end-of-life care, J Am Osteopath Assoc, 105, 18S

10.1016/0197-2456(95)00134-4

10.1089/jpm.1999.2.209

10.1097/00002508-200309000-00002

aaiPharma. Methadone injection CII. Manufactured by AAI Development Services in Charleston, SC; Distributed by aaiPharma in Wilmington, NC 2004.

Jacox A Carr DB Payne R Management of cancer pain. Clinical guideline number 9. Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service; 1994 Mar. Report No.: AHCPR Publication No. 94–0592.

10.1056/NEJM199403033300926

Rapp, 2000, Understanding equianalgesic dosing, Orthop Nurs, 19, 65, 10.1097/00006416-200019030-00010

Brant, 2001, Opioid equianalgesic conversion: The right dose, Clin J Oncol Nurs, 5, 163

FDA. Patient information: Duragesic® (fentanyl transdermal system). Manufactured by ALZA Corporation; Distributed by Janssen Pharmaceutica Products, L.P. 2003.

Levy, 1994, Pharmacologic management of cancer pain, Semin Oncol, 21, 718

10.1016/0304-3959(95)00180-8

10.1016/S0885-3924(99)00083-4

10.1016/j.jpainsymman.2005.12.005

10.1191/0269216306pm1099oa

10.1097/01.ftd.0000211827.03726.e4

10.1002/1097-0142(19931001)72:7<2266::AID-CNCR2820720734>3.0.CO;2-P

Eugenio, 2004, Profound morphine tolerance following high-dose methadone therapy, J Pain Palliat Care Pharmacother, 18, 47, 10.1080/J354v18n04_05

Hays, 1999, Use of methadone in treating chronic noncancer pain, Pain Res Manage, 4, 23, 10.1155/1999/343209

10.1016/S0304-3959(97)00118-8

10.1016/S0885-3924(99)00049-4

10.1053/rapm.2002.31937

10.1177/026921639400800209

10.1016/S0885-3924(01)00389-X

10.1191/0269216303pm696oa

10.1002/(SICI)1097-0142(19960815)78:4<852::AID-CNCR23>3.0.CO;2-T

10.1016/0885-3924(95)00191-3

10.1016/0885-3924(95)00021-P

10.1016/S0304-3959(96)03313-1

Oneschuk, 2000, Case report: Respiratory depression during methadone rotation in a patient with advanced cancer, J Palliat Care, 16, 50, 10.1177/082585970001600209

10.1016/0885-3924(95)00011-M

10.1016/0304-3959(96)03112-0

10.1016/S0305-7372(96)90075-4

Zimmermann, 2005, Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?, J Pain Palliat Care Pharmacother, 19, 25

10.1200/JCO.2005.13.128

10.1002/cncr.20712

10.1002/1097-0142(20011001)92:7<1919::AID-CNCR1710>3.0.CO;2-G

10.1017/S0317167100004236

10.1136/bmj.282.6266.771

10.1177/104990910502200411

Mironer, 1999, Successful use of methadone in neuropathic pain: A multicenter study by the national forum of independent pain clinicians, Pain Digest, 9, 191

10.1016/S0304-3959(01)00465-1

10.1016/j.jpainsymman.2005.02.006

10.1016/j.ctrv.2006.03.001

Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev 2004;(3):CD004847.

National Hospice and Palliative Care Organization. NHPCO's facts and figures—2005 findings. 2006 Nov. Available at: http://www.nhpco.org/files/public/2005-facts-and-figures.pdf (accessed December 15, 2006).

10.2165/00003088-200241140-00003

DeConno, 1996, Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients, J Clin Oncol, 14, 2836, 10.1200/JCO.1996.14.10.2836

10.1002/(SICI)1097-0142(19980915)83:6<1244::AID-CNCR26>3.0.CO;2-4

10.1046/j.1526-4637.2003.03020.x

10.1016/S0885-3924(00)00145-7

10.1007/s005200050026

10.1038/clpt.1992.38

10.1111/j.1365-2125.1987.tb03080.x

10.2165/00003088-200443140-00003

10.1016/S0140-6736(87)91034-8

10.1038/clpt.1985.194

10.1046/j.1526-4637.2003.03031.x

10.1016/S0304-3959(98)00138-9

10.1016/S0304-3959(99)00073-1

10.1016/j.jpainsymman.2003.04.002

U.S. Food and Drug Administration. FDA public health advisory. Methadone use for pain control may result in death and life-threatening changes in breathing and heart beat. Available at: http://www.fda.gov/cder/drug/advisory/methadone.htm (accessed November 30, 2006).

Fisch MJ Cleeland CS. Managing cancer pain. In: Sheet RT , ed. Handbook of Cancer Chemotheapy, 6th edition. Philadelphia, PA: Lippincott Williams & Wilkins; 2003:663.

10.1016/j.phrs.2004.05.002

Lugo, 2005, Pharmacokinetics of methadone, J Pain Palliat Care Pharmacother, 19, 13, 10.1080/J354v19n04_05

10.1111/j.1526-4637.2006.00289.x

10.1016/j.jbi.2006.10.004

10.1016/S0304-3959(03)00205-7

10.1592/phco.23.6.802.32186

10.1016/S0304-3959(02)00461-X

10.7326/0003-4819-137-6-200209170-00010

10.1093/pubmed/fdl059

Gagajewski, 2003, Methadone-related deaths in Hennepin County, Minnesota: 1992–2002, J Forensic Sci, 48, 668, 10.1520/JFS2002424

10.1111/j.1467-842X.2002.tb00185.x

10.1111/j.1467-842X.2002.tb00188.x

10.1111/j.1360-0443.2004.00956.x

Wolf, 2004, Methadone-related deaths in Palm Beach County, J Forensic Sci, 49, 375, 10.1520/JFS2003221